The evaluation of bone mineral density in long-term survival patients after allogeneic hematopoietic stem cell transplantation: cross sectional study by KSGCT
Not Applicable
- Conditions
- Hematological malignancies
- Registration Number
- JPRN-UMIN000030916
- Lead Sponsor
- Kanto Study Group for Cell Therapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who are otherwise classified as unfit by the attending physicians for this research. 2) Patients who underwent allogeneic and/or autologous transplantation more than once 3) Patients with multiple myeloma
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The prevalence of osteoporosis( score =< -2.5)after allogeneic hematopoietic stem cell transplantation
- Secondary Outcome Measures
Name Time Method 1) The prevalence of osteopenia(-2.5 < T score =< -1.0)after allogeneic hematopoietic stem cell transplantation 2) The effect of patient characteristics on osteopenia or osteoporosis 3) The effect of menses discontinuation on osteopenia or osteoporosis 4) The effect of post-transplant complication such as GVHD (graft versus host disease) on osteopenia or osteoporosis 5) The effect of therapeutic intervention on osteopenia or osteoporosis 6) The effect of SRE (skeletal related events) on osteopenia or osteoporosis